Recruiting leaders across the continuum of healthcare, we help to build the companies that are allowing people to live longer, healthier lives. Below, please find highlights of our Board and Executive Search work from 2019.

Board Members

  • Aetion (New York, NY), Director — To be announced
  • Alkermes (Dublin, Ireland), Director — Richard Gaynor, M.D. (President of Research and Development, Neon Therapeutics)
  • Alkermes (Dublin, Ireland), Director — Andy Wilson (Former Chief Financial Officer, PerkinElmer)
  • Carisma Therapeutics (Philadelphia, PA), Director — To be announced
  • Change Healthcare (Nashville, TN), Advisory Board — 12 Advisory Board Directors across clinical, technology, and strategic committees
  • CRISPR Therapeutics (Zug, Switzerland), Director — Katherine High, M.D. (President and Head of R&D, Spark Therapeutics)
  • CRISPR Therapeutics (Zug, Switzerland), Director — John T. Greene (Former Executive Vice President and Chief Financial Officer, Bioverativ)
  • Erytech Pharmaceuticals (Lyon, France), Director (Chairperson) — Jean-Paul Kress, M.D. (Former President and CEO and a member of the Board of Directors, Syntimmune)
  • Insulet Corporation (Acton, MA), Director — Corinne Nevinny (General Partner, LMNVC)
  • Insulet Corporation (Acton, MA), Director — Jim Hollingshead, Ph.D. (President, Sleep Business, ResMed)
  • Rhythm Pharmaceuticals (Boston, MA), Director — Stuart Arbuckle (Executive Vice President and Chief Commercial Officer, Vertex Pharmaceuticals)
  • Rubius Therapeutics (Cambridge, MA), Director — Anne Prener, M.D., Ph.D. (Former Chief Executive Officer, Freeline Therapeutics)
  • Ziopharm Oncology (Boston, MA), Director – Chris Bowden, M.D. (Chief Medical Officer, Agios Pharmaceuticals)
  • Ziopharm Oncology (Boston, MA), Director — Heidi Hagen (Co-Founder and Chief Strategy Officer, Vineti)

Chief Executive Officer | Chief Operating Officer

Business Development and Corporate Strategy

  • Carisma Therapeutics (Philadelphia, PA), Chief Business Officer — Tom Wilton
  • Checkmate Pharmaceuticals (Cambridge, MA), Chief Business Officer — Kleem Chaudhary, Ph.D.
  • Collegium Pharmaceutical (Stoughton, MA), Executive Vice President, Strategy and Corporate Development — Bart Dunn
  • Complexa (Berwyn, PA), Chief Business Officer Elisabeth Leiderman, M.D.
  • Seattle Genetics (Bothell, WA), Product Team Leader, ADCETRIS — Robb Fairbairn
  • Seattle Genetics (Bothell, WA), Product Team Leader, Portfolio Strategy & Management — Samir Vattompadam, M.S.


  • Blueprint Medicines (Cambridge, MA), SVP, Market Access — Lauren (Geyer) Barnes, M.H.S.
  • Change Healthcare (Nashville, TN), SVP, Payer Account Management — To be announced
  • Sarepta Therapeutics (Cambridge, MA), GM and Head of US Commercial — Maria Törnsén, M.Sc.


Human Resources

  • Magenta Therapeutics (Cambridge, MA), Chief People Officer — To be announced

 Research & Development

Perspective is committed to building great companies advancing human health. As an executive search firm serving biopharmaceutical and healthcare companies, we identify the right leaders and teams to drive growth, recruiting board directors, chief executive officers, and members of senior leadership. Our expertise extends across multiple functions and disciplines, including business, scientific, medical, technology, and corporate leaders.

Our Partners

Tom Carey
CEO, Board Practice Lead

Noël Auguston
Partner, Healthcare Practice Lead

Marshall Crane
Partner, Biopharma Practice Co-Lead

Kara Coluccio Bern
Partner, Biopharma Practice Co-Lead

268 Summer Street, 3rd Floor
Boston, MA 02210

New York
434 West 33rd Street, #704
New York City, 10001

Contact Us:

Follow Us:    LinkedIn Icon    Twitter Icon

Privacy Policy

© 2020 Perspective

© 2020 Perspective Group

268 Summer Street, 3rd Floor

Boston, MA 02210



434 West 33rd Street, #704

New York City, 10001